PPARA and metabolic dysfunction-associated steatotic liver disease: While the biological and social factors contributing to sex differences in metabolic and cardiovascular conditions as well as liver metabolism are complex and manifold (as reviewed here [236] and here [237]), one particular target of NAFLD treatment that has been identified as eliciting sexually dimorphic responses is PPARα [11].